Toronto, Ontario–(Newsfile Corp. – October 29, 2025) – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the “ Company “), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces, as approved by the shareholders of the Company at the annual general and special meeting of shareholders held on September 26, 2025, a non-brokered private placement of up to 30 class A multiple voting shares of the Company (“ Class A Multiple Voting Shares “) at a price of $25 per Class A Multiple Voting Shares, for aggregate gros

See Full Page